Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT).
Blood Cancer J
; 10(5): 53, 2020 05 11.
Article
in En
| MEDLINE
| ID: mdl-32393732
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dexamethasone
/
Antineoplastic Combined Chemotherapy Protocols
/
Bortezomib
/
Lenalidomide
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Blood Cancer J
Year:
2020
Document type:
Article
Affiliation country:
United States